Cost-effectiveness and public health impact of using high dose influenza vaccine in the Japanese older adults
These results indicate that HD vaccine has a high economic value in Japan compared to SD. Implementing HD vaccine could effectively alleviate the burden on healthcare facilities for Japanese OAs.
Authors
- Takeshi Arashiro (ORCID: https://orcid.org/0000-0002-5215-1500)
- Xinyu Wang (ORCID: https://orcid.org/0009-0009-3151-8092)
- Mafalda Nascimento Costa (ORCID: https://orcid.org/0000-0002-8088-754X)
- F. Bianic (ORCID: https://orcid.org/0009-0004-2039-2459)
- Caroline de Courville (ORCID: https://orcid.org/0000-0001-9396-6071)
- Mohit Joshi (ORCID: https://orcid.org/0000-0002-3941-5284)
- Chiho Tadera
Institutions
- Sanofi (France) (FR)
- Syneos Health (United States) (US)
- Syneos Health (India) (IN)
- Sanofi (Japan) (JP)
- Sanofi (Mexico) (MX)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/13696998.2025.2488151
- Citations
- 3
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.06